Recent studies have highlighted the critical role of RNA m6A modification in PAAD development, with the novel m6A methyltransferase METTL16 implicated in regulating key gene expression and signaling pathways, thereby influencing tumor proliferation, invasion, and therapeutic response. The gene discussed is METTL16; the disease is pancreatic adenocarcinoma.